Pyxis Oncology (PYXS) Intangibles (2023 - 2025)

Pyxis Oncology (PYXS) has 3 years of Intangibles data on file, last reported at $2.4 million in Q3 2025.

• On a quarterly basis, Intangibles fell 89.69% year-over-year to $2.4 million in Q3 2025; TTM through Sep 2025 was $2.4 million, a 89.69% decrease from a year earlier, with the FY2024 full-year figure at $23.9 million, down 2.42% from the prior year.
• Intangibles for Q3 2025 stood at $2.4 million, down from $2.5 million in the prior quarter.
• Over the last five years, Intangibles for PYXS reached as high as $24.5 million in Q4 2023 and fell as low as $2.4 million in Q3 2025.
• Historically, Intangibles has averaged $16.6 million across 3 years, with a median of $23.6 million in 2024.
• Across the five-year window, Intangibles increased 5.94% in 2024 and slumped 89.69% in 2025, its largest moves.
• Year by year, Intangibles stood at $24.5 million in 2023, then retreated by 2.42% to $23.9 million in 2024, then sank by 89.8% to $2.4 million in 2025.
• Per Business Quant data, the three most recent Intangibles figures were $2.4 million in Q3 2025, $2.5 million in Q2 2025, and $2.5 million in Q1 2025.